- Investing Ideas
- /
- Japanese Biotech Breakthroughs
Japanese Biotech Breakthroughs
Results
5
Biotech stocks worldwide which are expected to become profitable in the next 3 years.
5 companies
GNI Group
Market Cap: JP¥134.2b
Engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally.
2160
JP¥2,412.00
7D
-3.2%
1Y
-29.2%
Noile-Immune Biotech
Market Cap: JP¥5.8b
Researches and develops CAR-T cells for cancer immunotherapies.
4893
JP¥133.00
7D
-2.2%
1Y
-21.8%
SanBio
Market Cap: JP¥121.7b
Develops, produces, and sells regenerative cell medicines for the central nervous system.
4592
JP¥1,690.00
7D
4.7%
1Y
125.0%
Japan Tissue Engineering
Market Cap: JP¥25.3b
Engages in the regenerative medicine business in Japan.
7774
JP¥622.00
7D
25.7%
1Y
34.3%
Takara Bio
Market Cap: JP¥95.7b
Engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally.
4974
JP¥795.00
7D
0.5%
1Y
-24.3%